WOMEN WITH CORONARY HEART DISEASE ARE LESS AGGRESSIVELY TREATED WITH LIPID LOWERING MEDICATIONS THAN MEN

Abstract

Coronary heart disease (CHD) is the leading cause of death in women in the United States, and lipid-lowering therapy can reduce CHD events in women. Previous studies have shown that women are less likely to achieve optimal low-density lipoprotein (LDL) levels compared to men. We hypothesized that